LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 84 filers reported holding LEAP THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $89,900 | -85.0% | 264,413 | -80.1% | 0.00% | -87.0% |
| Q4 2022 | $597,578 | -48.9% | 1,327,952 | 0.0% | 0.02% | -53.1% |
| Q3 2022 | $1,169,000 | -23.4% | 1,327,952 | 0.0% | 0.05% | -15.5% |
| Q2 2022 | $1,527,000 | -34.3% | 1,327,952 | 0.0% | 0.06% | -18.3% |
| Q1 2022 | $2,324,000 | -46.0% | 1,327,952 | 0.0% | 0.07% | -40.8% |
| Q4 2021 | $4,303,000 | -19.2% | 1,327,952 | 0.0% | 0.12% | -20.0% |
| Q3 2021 | $5,325,000 | +256.9% | 1,327,952 | +45.9% | 0.15% | +328.6% |
| Q2 2021 | $1,492,000 | -13.7% | 910,047 | 0.0% | 0.04% | -10.3% |
| Q1 2021 | $1,729,000 | -27.9% | 910,047 | -14.6% | 0.04% | -29.1% |
| Q4 2020 | $2,397,000 | +187.8% | 1,065,259 | +153.3% | 0.06% | +161.9% |
| Q3 2020 | $833,000 | – | 420,471 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 16,952,992 | $27,802,000 | 0.18% |
| Opaleye Management Inc. | 540,000 | $886,000 | 0.15% |
| ACT CAPITAL MANAGEMENT, LLC | 134,000 | $220,000 | 0.11% |
| Artal Group S.A. | 3,000,000 | $4,920,000 | 0.10% |
| HHLR ADVISORS, LTD. | 3,575,745 | $5,864,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 910,047 | $1,492,000 | 0.04% |
| PERSONAL CFO SOLUTIONS, LLC | 78,165 | $128,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 122,401 | $201,000 | 0.02% |
| Windsor Creek Advisors, LLC | 46,955 | $77,000 | 0.02% |
| Golden Green, Inc. | 14,824 | $24,000 | 0.02% |